A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
Kidney Int Rep
.
2017 May 17;2(6):1238-1242.
doi: 10.1016/j.ekir.2017.05.006.
eCollection 2017 Nov.
Authors
Joseph Wang
1
,
Beth Vogt
2
,
Sidharth Kumar Sethi
3
,
Matthew G Sampson
4
,
Virginia Vega-Warner
4
,
Edgar A Otto
5
,
Rupesh Raina
6
Affiliations
1
Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania, USA.
2
Pediatric Nephrology, Rainbow Babies and Children's Hospital at Case Western Reserve University, Cleveland, Ohio, USA.
3
Pediatric Nephrology, Kidney Institute, Medanta, The Medicity, Gurgaon, Haryana, India, 122001 School of Medicine.
4
Department of Pediatrics-Nephrology University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
5
Department of Internal Medicine-Nephrology University of Michigan School of Medicine. Ann Arbor, Michigan, USA.
6
Department of Pediatric Nephrology, Akron Children's Hospital, Cleveland, Ohio, USA.
PMID:
29270533
PMCID:
PMC5733768
DOI:
10.1016/j.ekir.2017.05.006
No abstract available
Publication types
Case Reports